Featured Testimonials
Director - Global Regulatory Affairs – Operations
India-based, Global Top Generic Pharma Company
Medicinal Products
Regulatory Affairs
India
Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified by the GRA Lead. This continuously demonstrates Freyr's commitment to our company's milestones - keeping the patient in mind.
Manager-Regulatory Affairs
US-based, Leading Generic Pharmaceutical Company
Medicinal Products
Regulatory Affairs
USA
Thanks for your extreme support during the submission. It’s my pleasure to work with you. Without your hard work and dedication to work, I guess we could not have completed the task on time.
Best of luck with your future projects, and I appreciate your efforts!!!
Quality Control and Regulatory Manager
US-based, Nutraceutical Products Manufacturing Company
Medicinal Products
Regulatory Affairs
USA
This project, eCTD DMF conversion, was against a very tight schedule and required dedicated resources. Freyr provided the dedicated resources needed to meet our immediate Regulatory filing requirements. Freyr was always on schedule/or exceeded the dates outlined in the project plan. All changes were handled within 24 hours, and notifications of changes were promptly provided. This project is not yet complete but has been very successful until this point.
GM (General Manager)- Global Clinical Development
India-based, Global Pharmaceutical and Biotechnology Company
Medicinal Products
Regulatory Affairs
India
Overall, it was a great experience working with Freyr’s team, and we were quite happy with the feedback the team shared.
Director, Regulatory Affairs
US-based, Leading Precision Medicines Development Company
Medicinal Products
Regulatory Affairs
USA
We have had a good impression of Freyr and feel more than comfortable telling partners that we are engaging with Freyr for our Regulatory needs. The project went very smoothly, and we felt it went along at a reasonable pace. The team was knowledgeable, friendly, and accommodating. Rapid response is appreciated. Keep up the good work.
Director, Regulatory Affairs
US-based, Leading Precision Medicines Development Company
Medicinal Products
Regulatory Affairs
USA
I am very satisfied with Freyr's credibility in my interactions. I received good advice that was above board. We had previously employed a consulting group that specialized in policy strategy, and Freyr accommodated those needs and got to preparing and filing our application with the FDA. This was very important to me, and I will use Freyr's services in the future. Speed of service, responsiveness, attention to my needs, quality of product, and price are all very good in my work with Freyr.
We had a transition from one team to another during the process, and it worked out well. Service was delivered appropriately and in a timely fashion. Thankful to Freyr's responsive team because of which we could comprehend our unusual needs. In our interaction, I received good suggestions and advice, and the Freyr team was able to adapt to my needs. Because we are always working under time constraints, this was very important. I felt we were able to respond to shifts quickly. Anytime I had a question or needed support, I got rapid responses and good answers to my queries. Rapid responses and the ability to shift direction when needed were very good. I thought the support was very good and met with expectations. In addition, found the price reasonable, given the workload.
Global CMC Technical Lead
China-based, Leading Innovator Pharmaceutical Company
Medicinal Products
Regulatory Affairs
UK
We are extremely happy to inform you that the BLA was successfully submitted to the FDA. We convey our sincere gratitude to the Freyr team, who worked diligently, tirelessly, and very closely with our teams over the past several months to accomplish this monumental feat on a timely basis. Freyr’s team went beyond the call of duty to make this BLA submission come true. We truly appreciate Freyr’s flexibility and eagerness to work with us to accomplish aggressive goals.
Look forward to your perennial support and our continued relationship and
Senior Director of Business and Product Development
US-based, Leading Innovator Pharmaceuticals Company
Medicinal Products
Regulatory Affairs
USA
The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company.
Thank you again, and we look forward to working with your team on the next project!
CEO
US-based, Leading Innovative Pharmaceuticals Company
Medicinal Products
Regulatory Affairs
USA
Thank you all for the great support!
Assistant Manager
US-based, Leading, Complex Generic Pharmaceutical Products Company
Medicinal Products
Regulatory Affairs
USA
Congratulations!!!
Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.